Ming Liu

Ming Liu

Auto-generated profile, based on publicly available information

Ming Liu

M. Liu, MSc, Human Genetics & Genomics, Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2025 in Rheumatology
Verified
Journal Article
Closed access
AJAfshin Jamshidi
Afshin Jamshidi
GZGuangju Zhai
Guangju Zhai
MLMing Liu
Ming Liu
WZweidong zhang
weidong zhang
GJGraeme Jones
Graeme Jones
JMJohanne Martel-Pelletier
Johanne Martel-Pelletier
Objectives: Osteoarthritis (OA) is the most prevalent chronic musculoskeletal disease. Early identification of individuals at risk of knee structural progression is essential for targeted interventions. This study aimed to develop and validate a machine/deep learning (ML/DL)-based prognostic model for knee OA progression using serum metabolomics. Methods: Baseline serum metabolomic factors from two independent cohorts were analysed: Tasmanian Older Adult Cohort (n = 180) for model development and Licofelone trial (n = 137) for external validation. Participants were categorized by likelihood of knee structural progression using MRI and X-ray data. Four metabolomic scenarios were evaluated: metabolites alone (104), plus their ratios or inverse ratios (each 5460) and all combined (10 816), alongside age, sex, BMI. Metabolomic profiling used high-throughput omics. Batch effects were corrected via ComBat. Feature selection combined variable clustering with elastic net regularization. Top-selected features of each scenario were trained using five ML/DL models, with performance assessed by AUC, accuracy, sensitivity and specificity with 95% CIs. Results: The metabolomic-only scenario, including sex and age, yielded the best performance. Feature clustering reduced to 22, with the top 10 used for training/testing. The Artificial Neural Network with domain-adversarial component outperformed other algorithms with domain shift. The final model, including six metabolites (SM (OH) C22:2, proline, citrulline, LysoPC a C18:0, glutamate and C12-DC), plus sex and age, demonstrated excellent predictive performance (test: AUC 0.98 [0.95, 1], accuracy 0.89 [0.84, 0.94]; validation: AUC 0.89 [0.83, 0.95], accuracy 0.85 [0.79, 0.91]). Conclusion: This validated metabolomics DL framework (https://github.com/AFSHINJAM/KOA_Prediction_Metabolomics_Ratios) introduces a novel approach for predicting knee OA structural progression, enabling personalized risk assessment and early intervention.

1 July 2026 in The Journal of Rheumatology
Verified
Journal Article
Closed access
JHJingyi Huang
Jingyi Huang
MLMing Liu
Ming Liu
HZHongwei Zhang
Hongwei Zhang
GSGuang Sun
Guang Sun
AFAndrew John Furey
Andrew John Furey
GZGuangju Zhai
Guangju Zhai
Objective: Emerging evidence has suggested that distinct gut microbial profiles might differentially contribute to the development of knee and hip osteoarthritis (OA). The aim of current study was to identify gut microbial alteration and their potential functional consequences in primary knee and hip OA. Methods: Fecal and fasting plasma samples were collected from 24 knee OA, 24 hip OA, and 12 age, sex, and BMI matched OA-free controls. Gut microbiota were profiled by 16S rRNA gene sequencing, and plasma metabolomic profiling was performed. MaAsLin2 with ZINB model was applied to identify significantly differentially abundant taxa, which were then integrated with plasma metabolomic profiles to assess functional associations. Results: Hip OA patients showed significantly lower α-diversity compared to controls (P<0.05), while β-diversity did not differ among groups. MaAsLin2 identified 4 microbial taxa differing between knee OA and controls, 6 between hip OA and controls, and 11 between knee OA and hip OA (P<7.48×10 -5 ). These taxa were correlated with 117, 247, and 189 metabolites, respectively (P<0.05), enriched in arginine biosynthesis, sphingolipid metabolism, and one carbon pool by folate. sPLS-DA showed that these metabolites moderately distinguished OA patients from controls. Conclusion: Gut microbiome and metabolome signatures in knee and hip OA exhibited both shared and joint-specific features, suggesting potential distinct microbiome-driven mechanisms in OA pathogenesis. These signatures were linked to inflammatory, amino acid, lipid, and vitamin metabolic pathways, underscoring the potential for personalized and joint-specific approaches in microbiome-based interventions.